Invesco
SRNE

Invesco’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Invesco’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-149,982
Closed -$133K – 4071
2022
Q4 		$133K Buy
149,982
+27,971
+23% +$37.1K ﹤0.01% 3779
2022
Q3 		$192K Buy
122,011
+3,519
+3% +$7.98K ﹤0.01% 3694
2022
Q2 		$238K Sell
118,492
-4,701
-4% -$8.13K ﹤0.01% 3660
2022
Q1 		$287K Sell
123,193
-4,810
-4% -$15K ﹤0.01% 3654
2021
Q4 		$596K Buy
128,003
+7,660
+6% +$47.6K ﹤0.01% 3319
2021
Q3 		$919K Buy
120,343
+23,142
+24% +$196K ﹤0.01% 3141
2021
Q2 		$942K Buy
97,201
+34,463
+55% +$274K ﹤0.01% 3141
2021
Q1 		$519K Sell
62,738
-42,570
-40% -$450K ﹤0.01% 3326
2020
Q4 		$719K Sell
105,308
-89,206
-46% -$717K ﹤0.01% 3069
2020
Q3 		$2.17M Sell
194,514
-1,555,220
-89% -$14.2M ﹤0.01% 2452
2020
Q2 		$11M Buy
1,749,734
+1,667,976
+2,040% +$6.39M ﹤0.01% 1591
2020
Q1 		$150K Sell
81,758
-11,905
-13% -$34.3K ﹤0.01% 3482
2019
Q4 		$317K Sell
93,663
-6,199
-6% -$14.8K ﹤0.01% 3405
2019
Q3 		$214K Sell
99,862
-3,953
-4% -$9.21K ﹤0.01% 3534
2019
Q2 		$277K Sell
103,815
-3,573
-3% -$12.9K ﹤0.01% 3523
2019
Q1 		$510K Buy
+107,388
New +$282K ﹤0.01% 3306
2018
Q4 		– Sell
-1,368,184
Closed -$6.02M – 3896
2018
Q3 		$6.02M Buy
+1,368,184
New +$7.58M ﹤0.01% 2037
2015
Q3 		– Sell
-329
Closed -$6K – 4059
2015
Q2 		$6K Buy
+329
New +$4.23K ﹤0.01% 4144

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Invesco's SRNE Position: Q1 2023 in Review

Invesco sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 149,982 shares — an estimated $133K sold.

Invesco first reported a position in SRNE in Q2 2015 and held it in 18 quarters. The position peaked at $11M in Q2 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Invesco reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Invesco sold 149,982 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $133K.
  • Invesco first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and held it in 18 quarters.
  • Invesco's Sorrento Therapeutics, Inc. position peaked at $11M in Q2 2020.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Invesco's 13F filing for Q1 2023, filed 12 May 2023.